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Lysosomal protease deficiency or substrate
overload induces an oxidative-stress mediated
STAT3-dependent pathway of lysosomal
homeostasis
Jonathan Martínez-Fábregas1, Alan Prescott1, Sander van Kasteren 2, Deena Leslie Pedrioli3,7,
Irwin McLean 3, Anna Moles4,8, Thomas Reinheckel5, Valeria Poli 6 & Colin Watts 1
Diverse cellular processes depend on the lysosomal protease system but how cells regulate
lysosomal proteolytic capacity is only partly understood. We show here that cells can
respond to protease/substrate imbalance in this compartment by de novo expression of
multiple lysosomal hydrolases. This response, exemplified here either by loss of asparagine
endopeptidase (AEP) or other lysosomal cysteine proteases, or by increased endocytic
substrate load, is not dependent on the transcription factor EB (TFEB) but rather is triggered
by STAT3 activation downstream of lysosomal oxidative stress. Similar lysosomal adapta-
tions are seen in mice and cells expressing a constitutively active form of STAT3. Our results
reveal how cells can increase lysosomal protease capacity under ‘fed’ rather than ‘starved’
conditions that activate the TFEB system. In addition, STAT3 activation due to lysosomal
stress likely explains the hyperproliferative kidney disease and splenomegaly observed in
AEP-deficient mice.
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Endosomes and lysosomes are now known to participate inmultiple aspects of cell and tissue physiology besides theirclassical role in degradation of endocytosed substrates. They
host key signalling systems such as the nucleic acid sensing Toll-
like receptors (TLRs)1,2 and mTOR pathway3,4, and they generate
immunological information through class II MHC-mediated
antigen presentation5,6. Lysosomal proteases can drive a physio-
logically important caspase-independent cell death pathway7,8,
and lysosome-like organelles allow cytotoxic leucocytes such as
CD8 T cells, mast cells and eosinophils to execute their specific
functions9. In addition, lysosomes are central to autophagy10.
Most of these functions depend on protease activities found in the
lysosomal lumen. Because these hydrolytic events are separated
from the major cellular signalling pathways by the lysosomal
membrane until recently it has not been obvious how a
requirement for more or less hydrolytic capacity would be sig-
nalled to the cytosol and onwards to the transcriptional
apparatus.
How lysosomal gene expression is controlled was advanced
substantially by the identification of a signalling pathway that
leads to the activation of transcription factor EB (TFEB)11,12. In
response to cellular starvation, some types of lysosomal stress and
some lysosomal storage diseases, TFEB translocated from the
cytosol to the nucleus to drive the transcription of a variety of
genes involved in lysosomal and autophagic function3,13. TFEB is
negatively regulated by sequestration in the cytosol but in
response to nutrient deprivation and reduced mTORC1 activity it
becomes dephosphorylated, enters the nucleus and activates its
target genes. In addition, a PKC-dependent but mTORC1-
independent pathway for TFEB activation was recently descri-
bed14. As important as this pathway is, there are reasons to
suspect that additional regulatory mechanisms of lysosomal
hydrolytic capacity may exist. For example, an increase in lyso-
somal protein substrate load and/or the accumulation of unde-
graded protein substrates is not expected to induce the TFEB
pathway since this would be more consistent with a ‘fed’ rather
than starved state. Nonetheless, increased hydrolytic capacity is
likely needed to restore the status quo but how this would be
achieved in the absence of mTOR/TFEB signalling is not clear.
Deletion of individual murine lysosomal proteases results in
clear tissue-specific phenotypes illustrating that they have non-
redundant functions15–18. Lysosomal proteolytic capacity relies
mainly on three different enzyme families: the papain-like
cysteine proteases (e.g. cathepsins B and L), the pepsin-related
aspartyl proteases (cathepsins D and E) and a distinct cysteine
protease known as asparaginyl endopeptidase (AEP) or legu-
main19–21. AEP shows high specificity for cleavage after
asparagine19,20, suggesting it has specific processing functions.
Consistent with this, AEP has been shown to make activating
cleavages in TLR9 and TLR7 in dendritic cells1,22, and to parti-
cipate in antigen processing23. AEP has also been recently linked
to both exitoneurotoxicity and to neurofibrillary pathology
through its site-specific cleavage of the DNAse inhibitor SET and
tau, respectively24,25. Mice lacking AEP develop hyperprolifera-
tive kidney disease26 and several indications of hemophagocytic
lymphohistiocytosis including hepatosplenomegaly27. How the
absence of AEP triggers these hyperproliferative states is not
known, but AEP is particularly abundant in the kidney proximal
tubule19,26.
We demonstrate here a TFEB-independent, STAT3-dependent
signalling pathway for lysosomal protease homoeostasis triggered
by loss of lysosomal cysteine proteases or substrate overload.
Chronic or acute AEP-deficiency promotes STAT3-dependent
transcription of all three lysosomal protease families including
AEP itself as well as other hydrolases. Lysosomal oxidative stress
appears to be the primary driver of Jak2-STAT3 activation which
is also observed in the AEP-deficient kidney proximal tubular
system and which may explain the hyperproliferative disease and
loss of kidney function in AEP-null mice.
Results
The lysosome detects loss of AEP activity and responds by
increasing expression of multiple proteases. Deletion of AEP in
the murine kidney leads to proximal tubular cell (PTC) hyper-
plasia, interstitial fibrosis and eventually loss of kidney function26.
At the morphological level lysosomes appeared more prominent
in AEP-null kidney PTC and cathepsin D (CtsD) staining was
more intense (Fig. 1a, b) indicating accumulation of undegraded
material and/or increased expression of lysosomal proteins.
Indeed, the levels of CtsL, which accumulates in its active single
chain (SC) form when AEP is absent26,28, and other hydrolases
such as the active single chain form of CtsD were higher in AEP-
null kidney (Fig. 1c).
We investigated this further using kidneys from mice fed a diet
where 12C6-lysine is replaced by 13C6-lysine (‘SILAM mice’29) to
reveal the proteome of age-matched wildtype (WT) and AEP-null
kidney lysosomes (Supplementary Fig. 1a). In addition to proteins
we previously detected by 2D-difference gel analysis26
including SOD1, transthyretin (Ttr) and Ym1 (Figs. 1c, d, 2
and Supplementary Data 1), mass spectrometric and bioinfor-
matic analysis using the SILAM kidney as a reference sample
revealed a striking increase in multiple proteins associated with
lysosomes and peroxisomes in the AEP-null kidney (Figs. 1d, 2
and Supplementary Data 1) including cathepsins (Cts) A, B, C, L
and Z and other hydrolases such as hexosaminidase A and
hexosaminidase B, beta mannosidase (Manba) and ganglioside
GM2 activator (Gm2a). We validated these changes by direct
western blotting of WT and AEP-null kidney lysates (Fig. 1c).
Although there was a modest increase in Lamp1 it appeared to be
lysosomal contents rather than lysosomal membrane proteins
that were increased. Although some differentially represented
proteins may be undegraded AEP substrates, for example,
fibronectin (Fn1)30, the general increase in hydrolase levels
indicated an unexpectedly coordinated response to deletion of
AEP.
This response was not specific to the kidney or to the in vivo
state because many of the same proteins such as Gns and CtsD
were elevated in SILAC-labelled AEP-null mouse embryonic
fibroblasts (MEF; Fig. 1e and Supplementary Fig. 1b). Consistent
with these changes, direct protease activity measurements in cell
lysates (Fig. 1f) and in intact MEF (Supplementary Fig. 1c)
confirmed enhanced CtsD/E and CtsB/L activity in AEP-null
MEF. Moreover, the response could be induced acutely by
treatment of WT MEF with the AEP inhibitor MVO26630,
(hereafter MVO31) which led to increased Gns, CtsD and
importantly AEP itself (Fig. 1e, Supplementary Fig. 2a, b and
Supplementary Data 1). To assess reversibility of the phenotype,
we reconstituted AEP-null MEF with pro-AEP which is taken up
and converted to active AEP32. Restoration of AEP activity
reversed the accumulations seen in AEP-null MEF (Fig. 1e).
Increased protease levels was due to a transcriptional response
because chemical AEP inhibition increased mRNA levels of AEP,
CtsD and CtsL while genetic deletion of AEP induced even more
substantial mRNA increases for CtsD and CtsL (Fig. 1g). Thus,
loss of AEP activity promotes its own biosynthesis alongside
several other lysosomal hydrolases.
Increased lysosomal proteolytic capacity induced by suppres-
sion of AEP activity. These results suggested an interesting and
potentially important prediction: AEP ablation might actually
lead to faster degradation of substrates traversing the endocytic
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pathway. We tested this for an exogenously supplied substrate
and for two endogenous receptors. WT 3T3 fibroblasts, pre-
viously incubated with MVO to block AEP activity, were loaded
with DQ-BSA, whose fluorescence is quenched prior to protease
action. As shown in Fig. 3a, MVO-treated 3T3s showed stronger
fluorescence compared with untreated 3T3s consistent with
greater lysosomal protease capacity in the former. Moreover,
ligand-induced downregulation of oncostatin M receptor beta
(OSMRβ) and EGFR was faster in AEP-null and MVO-treated
WT MEF compared with WT MEF (Fig. 3b, c). Thus, unex-
pectedly, genetic or chemical ablation of AEP elicits a response
which, overall, leads to increased lysosomal proteolytic capacity.
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Fig. 1 In vivo SILAC labelling reveals elevated lysosomal hydrolase expression induced by lack of AEP. a Transmission electron microscopy of WT (upper
panel) and AEP−/− (lower panel) kidney sections. Arrows indicate lysosomes. (Scale bar= 2 μm) b Immunofluorescence showing more prominent
lysosomes (CtsD, green) in AEP−/− kidney sections (lower panel) compared to WT kidney sections (upper panel). (Scale bar= 20 μm). c Western blot
analysis confirming the accumulation in AEP−/− kidneys of proteins identified by mass spectrometry. d Volcano plot showing proteins over-represented
(blue dots, lysosomal proteins highlighted in yellow) or under-represented (red dots) in AEP−/− lysosomal kidney fractions against the −log10 p-value for
three independent experiments. Dotted line on y axis indicates p value < 0.05. e Acute AEP inhibition with MVO26630 recapitulates hydrolase induction in
WT MEF and AEP reconstitution reverses it in AEP−/− MEF. f Induction of CtsD/E and CtsB/L activities in AEP−/− MEF compared to WT MEF. Data are
the average ± SD of n= 4 biologically independent samples for CtsD/E or n= 3 biologically independent samples for CtsB/L. Statistical significance was
calculated using a two-sided unpaired t-test. g Semi-quantitative RT-PCR analysis of mRNA levels for different cathepsins in WT MEF, WT MEF treated
overnight with 50 μM MVO26630 and AEP−/− MEF. Data are the average ± SD of n= 3 biologically independent samples. Statistical significance was
calculated using a Dunnett’s multiple comparison test
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AEP suppression triggers a TFEB-independent increase in
lysosomal hydrolase expression. We performed various experi-
ments to test whether the upregulation of lysosomal hydrolases
following AEP inhibition was due to a TFEB response11,13. First,
we generated cells expressing TFEB-GFP and challenged them
either with MVO or with the mTORC1 inhibitor Torin1. For
these and some subsequent experiments, we utilised the human
kidney PTC line, HKC-833. As previously reported34, TFEB-GFP
showed a striking redistribution from cytosol to nucleus upon
mTORC1 inhibition (Fig. 4a). In contrast, TFEB remained
cytosolic in MVO-treated MEF (Fig. 4a) and in AEP-null kidney
PTC (Fig. 4b). In fact, in the latter case TFEB seemed to be
excluded from the nucleus to a greater extent compared to WT
PTC. This suggested elevated mTORC1 activity and indeed
phospho-4EBP1 levels were higher in AEP-null kidney (Fig. 4c).
Reduced mTORC1 activity leads to TFEB activation and down-
stream induction of autophagy genes13. To test further for a TFEB
response when AEP was ablated, we examined the autophagy
marker LC3 (microtubule-associated protein 1 light chain 3) in
MVO, Torin1 or rapamycin-treated MEF. As expected, inhibition
of mTORC1 induced a conversion of LC3-I to the phosphatidyl
ethanolamine-conjugated form LC3II consistent with increased
autophagic flux. In contrast, LC3 status, and therefore autophagy,
was unchanged upon AEP inhibition (Fig. 4d). To investigate this
apparent TFEB-independent response further, we used CRISPR-
Cas9 technology to eliminate TFEB expression in HKC-8 cells
(Supplementary Fig. 3a). As expected, upon starvation TFEB-null
cells no longer induced an increase in cathepsin expression
(Supplementary Fig. 3b). In contrast, when the same TFEB-null
cells were treated with MVO, there was still a robust increase in
expression of CtsD and CtsB at both protein (Fig. 4e) and mRNA
(Fig. 4f and Supplementary Fig. 3c) levels. Thus increased lyso-
somal hydrolytic capacity did not in this instance involve a TFEB
response.
Activation of STAT3 in AEP-deficient cells. Further analysis of
cytosolic fractions from SILAC-labelled AEP-null MEF revealed a
consistent increase both in the level and activation state of the
transcription factor STAT3 (Fig. 5a, Supplementary Fig. 4a and
Supplementary Data 1). Moreover, inhibition of AEP in WT MEF
with MVO or with two other mechanistically distinct AEP inhi-
bitors35 induced a dose-dependent increase in activated STAT3
(phospho-Tyr705-STAT3, hereafter P-STAT3) without affecting
the levels of total STAT3 (Fig. 5a and Supplementary Fig. 4b).
Importantly, P-STAT3 levels were already elevated in AEP-null
MEF and were not further increased by MVO demonstrating that
STAT3 was activated specifically by suppression of AEP activity
(Fig. 5a). Phosphorylation of STAT3 on Tyr705 results in
dimerisation and translocation into the nucleus36. P-STAT3 was
found in the nuclei of AEP-null MEF and MVO-treated WT MEF
but not untreated MEF (Fig. 5b). Similarly, in HKC-8 expressing
STAT3-YFP, suppression of AEP activity clearly triggered nuclear
translocation of STAT3 (Fig. 5b). MVO-treatment of HKC-8 cells
also induced a dose-dependent increase in P-STAT3 (Fig. 5c).
STAT3 mediates the lysosomal response to loss of AEP activity.
The notion that STAT3 rather than TFEB might control lysoso-
mal hydrolase expression under some conditions seemed plau-
sible since a STAT3-dependent increase in the expression of
several cathepsins during the involution of the mammalian
mammary gland was recently shown7,8. We took multiple
approaches to establish a link between STAT3 activation and
lysosomal hydrolase expression in our system. Small molecule
targeting of STAT3 with S3I-20137 not only blocked STAT3
phosphorylation but almost completely reversed the MVO-
induced increase in CtsD and CtsB levels in MEF (Fig. 5d and
Supplementary Fig. 5a). To confirm these results, we generated
STAT3-depleted HKC-8 cells by siRNA knockdown (Fig. 5e and
Supplementary Fig. 5b). Knockdown of STAT3 by two different
siRNAs suppressed the MVO-induced increase in CtsB and CtsD
protein levels, a result not seen with a non-targeting siRNA
control (Fig. 5e and Supplementary Fig. 5b). Further, we also
generated a STAT3 mutant (fused to GFP to distinguish it from
endogenous STAT3) designed to resist siRNA knockdown
(mSTAT3-GFP). MVO-induced induction of CtsD was rescued
in cells expressing mSTAT3-GFP, which in contrast to endo-
genous STAT3, was largely resistant to siRNA knockdown
(Supplementary Fig. 5c) demonstrating unequivocally a require-
ment for STAT3. Consistent with canonical activation of STAT3,
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Fig. 2 Lack of AEP induces an increase in the hydrolytic capacity of
lysosomes in vivo. Heatmap built using heatmap.2 in the gplots package of
R program showing proteins over-represented (red) or under-represented
(green) in the AEP−/− lysosomal kidney fractions compared to WT
samples as identified by our SILAC approach, organised by cellular location
and molecular function
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inhibition of Jak2 with the inhibitor SD-1029 suppressed MVO-
induced STAT3 phosphorylation (Fig. 5f and Supplementary
Fig. 5d). Moreover, MVO treatement of HKC-8 cells activated
Jak2, as indicated by enhanced phosphorylation on Tyr1007/1008
(Fig. 5g). To confirm the involvement of Jak2, we generated Jak2-
depleted cells. As shown in Fig. 5h and Supplementary Fig. 5e,
two different siRNAs directed to Jak2, but not a non-targeting
siRNA, suppressed MVO-induced STAT3 phosphorylation as
well as increased levels of CtsB and CtsD protein (Fig. 5h and
Supplementary Fig. 5e). Thus, ablation of AEP activates the
canonical Jak2-STAT3 pathway and leads to upregulation of
other lysosomal hydrolases.
Direct promotion of lysosomal hydrolase expression by
STAT3. Overall, 67% of proteins increased 1.5-fold or more in
AEP-null MEFs featured a canonical STAT3 site in their pro-
moters while almost 90% contained either canonical or non-
canonical STAT3 sites as defined in a recent study38. Although
this was consistent with STAT3 recruitment to lysosomal
hydrolase promoters it was important to test this directly in AEP
−/− versus WT cells. We immunoprecipitated STAT3-associated
chromatin fragments (ChIP) from WT and AEP−/− MEF and
compared the signal obtained by PCR from input versus pre-
cipitated DNA for key upregulated hydrolase genes. We observed
enhanced STAT3 recruitment to the promoters of CtsD, CtsL, the
still intact promoter region of the AEP gene and other hydrolase
genes in AEP−/− compared with WT cells (Fig. 6a, b and Sup-
plementary Fig. 6a). STAT3 recruitment to the AEP promoter
made sense of the initially puzzling observation that low levels of
MVO increased, rather than decreased AEP activity in cells.
Blockade of STAT3 with S3I-201 prevented this increase and
increased MVO potency at all concentrations (Fig. 6c). Taken
together, these results demonstrate direct involvement of STAT3
in regulation of lysosomal hydrolase expression when a key
lysosomal hydrolase activity is missing. Importantly, elevated
activity of AEP and CtsD was also observed in 3T3 fibroblasts
(Fig. 6f) expressing a constitutively active form of STAT3,
STAT3c, which dimerises in the absence of tyrosine
phosphorylation39,40, an increase which was again due to
increased protease mRNA levels in these cells (Fig. 6d and Sup-
plementary Fig. 6b).
Protein overload induces STAT3-dependent protease expres-
sion. If the response triggered by AEP ablation is due to accu-
mulation of undegraded substrates, we reasoned that a similar
response should be induced by substrate overload of the endo-
cytic pathway. To test this WT MEFs were incubated for 16 h
with 30 mg/ml BSA and the status of STAT3 as well as protease
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multiple comparison test. b Localisation of TFEB by IF in WT and AEP−/− kidney sections. (Scale bar= 20 μm). c Levels of P-4EBP1 by IF in WT and
AEP−/− kidney sections. (Scale bar= 20 μm). d Immunoblotting and quantitation of LC3II/total LC3 ratio in lysates from WT MEFs treated with
Rapamycin (1 μM) or Torin1 (1 μM) for 4 h or with MVO26630 (50 μM) for 16 h. Data are the average ± SD of n= 5 biologically independent samples.
Statistical significance was calculated using a Dunnett’s multiple comparison test. e Levels of expression of CtsB and CtsD in HKC-8 WT and TFEB
knockout Exon 1 treated or untreated with 50 μM MVO26630 for 16 h. Data are the average ± SD of n= 6 biologically independent samples for CtsB and
n= 7 biologically independent samples for CtsD. Statistical significance was calculated using a two-sided unpaired t-test. f mRNA expression levels for
CtsB and CtsD in HKC-8 WT and TFEB knockout Exon 1 treated or untreated with 50 μM MVO26630 for 16 h. Data are the average ± SD of n= 3
biologically independent samples. Full data and gel calibration markers can be seen in Supplementary Fig. 3c. Statistical significance was calculated using a
two-sided unpaired t-test
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mRNA levels and activities assessed. Protein overload led to a two
to sevenfold increase in the mRNA levels of several lysosomal
proteases including AEP, CtsB, CtsL, CtsD and CtsH (Fig. 6e and
Supplementary Fig. 7) consistent with an increase in protease
activity levels (Fig. 6g). This increase was blunted by STAT3
inhibition with S3I-201 (Fig. 6g). Importantly, increased protein
load also led to a striking increase in nuclear P-STAT3 similar to
that seen upon MVO-treatment (Fig. 6h) but without nuclear
translocation of TFEB (Supplementary Fig. 8a). In contrast,
mTORC1 inhibition with either rapamycin or Torin1 had no
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effect on P-STAT3 distribution but instead triggered focalised
LC3 accumulation on autophagosomes, a response that was not
observed either with MVO-treatment or protein overload
(Fig. 6h). This important result demonstrates that STAT3-driven
expression of lysosomal hydrolases is not a limited response to
the perturbations caused by loss of AEP activity but one induced
by increased load on the lysosomal system and therefore likely to
be of widespread physiological significance. Moreover, the pro-
tease/substrate imbalance conditions that activate STAT3 do not
signal through the mTORC1/TFEB pathway and conversely,
suppression of mTORC1 activity which activates TFEB does not
activate STAT3 (Fig. 6h).
Lysosomal stress triggers STAT3-dependent de novo protease
expression. STAT3 can be activated by a variety of exogenous
and endogenous stimuli including oxidative stress41,42. We pos-
tulated that oxidative stress following acute AEP inhibition might
be a driver of STAT3 activation since oxidative stress is a com-
mon feature of lysosomal storage diseases43. Consistent with this
scenario, SOD1 levels were elevated in both AEP-null kidney26
and MEF (Fig. 1c, d and Fig. 7a), and SOD1 activity was also
boosted following acute AEP inhibition with MVO (Fig. 7b). We
strengthened the link between AEP-deficiency, oxidative stress
and STAT3 activation in three ways. First, the ‘spin trap’ anti-
oxidant phenyl-α-tert butyl nitrone (PBN) completely blocked the
activation of STAT3 (Fig. 7c). Second, direct exposure to H2O2
induced the nuclear translocation of STAT3-YFP but not TFEB-
GFP in HKC-8 cells (Fig. 7d) and moreover, increased the level of
CtsD (Fig. 7e). Indeed, in H2O2 treated MEF, increased mRNA
levels for multiple lysosomal proteases were observed (Fig. 7f and
Supplementary Fig. 7). Third, CellROX Orange, a reporter dye
that fluoresces upon oxidation showed a twofold increase in
lysosomal labelling in AEP-null MEF and in WT MEF treated
with MVO compared to untreated WT MEFs (Fig. 7g), thus
identifying lysosomes as sites of ROS generation. Importantly,
protein overload of lysosomes also induced oxidative stress sig-
nals in lysosomes (Supplementary Fig. 8b), underlining that
STAT3 activation by lysosomal stress is a general response aimed
at recovering lysosomal homoeostasis induced by lysosomal
protease/substrate imbalance.
AEP ablation is linked to STAT3 activation in murine kidney
PTC in vivo and in human PTC. To test the physiological
relevance of the STAT3-driven response to lysosomal stress, we
re-examined kidneys from AEP-null mice and mice expressing
constitutively activated STAT3c. Indeed, levels of P-STAT3 were
higher in AEP-null kidney compared with WT although levels of
STAT3 protein appeared similar (Fig. 8a). Importantly, labelling
for P-STAT3 was particularly prominent in the PTC, which
exhibits the highest levels of AEP expression26 (Fig. 8b). This
finding most likely explains the hyperproliferative PTC pheno-
type observed in AEP-null kidney26 and confirmed here using
anti-Ki67 staining (Fig. 8c). Once again, increased expression of
lysosomal hydrolases could be uncoupled from AEP status since
kidneys from STAT3c mice44 also showed striking increases in
many of the proteins that were induced by AEP-deficiency or
protein overload including CtsD and CtsL, Ym1, Gns and AEP
(Fig. 8d). To test whether the response was conserved in primary
human kidney cells, we expanded PTC as well as distal tubular
cells (DTC) from biopsied human kidneys. MVO-treatment
induced STAT3 activation and increased expression of CtsD in
primary PTC but not in DTC (Fig. 8e).
STAT3 regulation of lysosomal capacity in cathepsin depleted
cells and tissues. Finally, we addressed two further important
questions: does ablation of lysosomal proteases besides AEP
induce STAT3-driven hydrolase expression and do tissues other
than the kidney show evidence of this response? First, we looked
for an acute in vitro response akin to that induced by MVO by
treating WT MEF with the cysteine cathepsin inhibitor E64 or the
aspartyl cathepsin inhibitor pepstatin. WT MEF treatment with
pepstatin increased P-STAT3 levels and boosted CtsD expression
substantially as did E64 albeit to a lesser extent (Fig. 9a). Next, we
examined tissues from mice genetically ablated for CtsL or B
which are both E64 targets. We examined heart since previous
studies had demonstrated a cardiomyopathic phenotype in ageing
CtsL-null mice and enlarged lysosomes in the myocardium45. In
CtsL-null heart (Fig. 9b), P-STAT3 and CtsD levels were
increased by at least a factor of 2 (Fig. 9b). Similar increases were
observed in CtsB-null heart tissue although no overt heart phe-
notype has been described in these mice. Moreover, as in cells and
tissues lacking AEP, SOD1 expression was also increased in Cts-
null tissues providing evidence that oxidative stress was a factor
once again (Fig. 9b). Thus, ablation of diverse lysosomal protease
activities can induce a STAT3-regulated response whose purpose
is presumably to restore homoeostasis.
Discussion
How cells tune the performance of their lysosomes to meet the
demand placed on them has only recently been investigated. A
particular challenge is to understand how the environment in the
lysosomal lumen is sensed and communicated to cytosolic
Fig. 5 Increased lysosomal hydrolytic capacity induced by chronic or acute AEP-deficiency is controlled by the Jak2-STAT3 signalling pathway. a STAT3
activation in WT but not AEP−/− MEFs treated for 16 h with increasing concentrations of MVO26630. Data are the average ± SD of n= 3 biologically
independent samples. Statistical significance was calculated using a Dunnett’s multiple comparison test. b P-STAT3 localisation in WT and AEP−/− MEFs
treated or not with 50 μM MVO26630 for 16 h (endogenous P-STAT3) and HKC-8 cells transfected with STAT3-YFP and treated or not with 50 μM
MVO26630 for 16 h. Data are the average ± SEM of n= 96 cells for control samples and n= 86 for MVO-treated samples. Statistical significance was
calculated using a two-sided unpaired t-test. (Scale bar= 20μm). c STAT3 activation in HKC-8 cells treated with increasing levels of MVO26630
overnight. Data are the average ± SD of n= 3 biologically independent samples. Statistical significance was calculated using a two-sided unpaired t-test.
d CtsD, CtsB and P-STAT3 levels in WT MEFs compared to WT MEFs treated overnight with 50 μM MVO26630 with or without 100 μM of the STAT3
inhibitor S3I-201. Data are the average ± SD of n= 3 biologically independent samples. Statistical significance was calculated using a two-sided unpaired t-
test. e Levels of STAT3, CtsB and CtsD in WT HKC-8 cells transfected with a non-targeting siRNA (NT) or two different STAT3-targeting siRNAs (#8 and
#10) and treated or not with 50 μM MVO26630 for 16 h. Data are the average ± SD of n≥ 3. Statistical significance was calculated using a two-sided
unpaired t-test. f P-STAT3 western blot in WT HKC-8 treated with 50 μM MVO26630 in the presence or absence of the Jak2 inhibitor SD-1029 (10 μM).
Data are the average ± SD of n= 3 biologically independent samples. Statistical significance was calculated using a Dunnett’s multiple comparison test.
g Levels of P-Jak2 in WT HKC-8 cells treated or untreated with 50 μM MVO26630 for 16 h. Data are the average ± SD of n= 3 biologically independent
samples. Statistical significance was calculated using a two-sided unpaired t-test. h Levels of Jak2, P-STAT3, CtsB and CtsD in WT HKC-8 cells transfected
with a non-targeting siRNA (NT) or two different Jak2-targeting siRNAs (#6 and #7) and treated or not with 50 μM MVO26630 for 16 h. Data are the
average ± SD of n≥ 3 biologically independent samples. Statistical significance was calculated using a two-sided unpaired t-test
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signalling pathways and the transcriptional machinery. Our
results show that when the capacity of the lysosome to ‘keep up’
with substrate load is compromised, either because of loss of a key
hydrolytic activity or because of increased endocytic load, oxi-
dative stress leads to activation of STAT3 and the de novo
transcription of a variety of lysosomal hydrolases. Although the
endpoint is similar, this pathway differs fundamentally from the
recently elucidated mTORC1-TFEB pathway for lysosomal
biogenesis46.
A mechanism for enhancing lysosomal capacity independent of
the mTORC1-TFEB pathway makes sense from several stand-
points. In particular, the cellular response to nutrient poor con-
ditions that promote autophagy would be expected to be different
to the response to conditions which can be characterised as
‘nutrient rich’ where exogenous proteins are abundant. Recent
studies have shown that cells can use bulk endocytic uptake
pathways such as macropinocytosis to capture proteins and
degrade them to meet nutritional demands and to drive cell
proliferation47,48. Under these conditions, enhanced generation
of amino acids in the lysosomal lumen would be expected to
maintain or even enhance mTORC1 activity precluding TFEB
activation. Indeed, most likely as a result of enhanced lysosomal
protein breakdown and amino acid availability, we observed tight
retention of TFEB on lysosomes under conditions that induced
STAT3 activation.
Although ‘nutrient poor’ and ‘protein nutrient rich’ conditions
both benefit from enhanced lysosomal capacity, other aspects of
cellular physiology in these states are quite different. For example,
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Fig. 6 Direct STAT3 involvement in regulation of lysosomal hydrolase genes under conditions of protease activity/lysosomal substrate imbalance.
a Agarose gel analysis of representative ChIP-PCR products for AEP, CtsD and CtsL promoters in WT and AEP-deficient MEFs. Full data and gel calibration
markers can be seen in Supplementary Fig. 6. b Quantitative PCR analysis of DNA from STAT3 ChIP of WT (blue circles) and AEP-deficient (red squares)
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two-sided unpaired t-test. c AEP activity in WT MEF treated overnight with different concentrations of MVO26630 in the presence (dashed line) or
absence (solid line) of 100 μM S3I-201. Data are the average ± SD of three independent experiments. d Quantitative PCR analysis of the mRNA levels for
different lysosomal proteases in WT (blue circles) and STAT3c 3T3 (red squares) cells. Data are the average ± SD of n= 6 biologically independent
samples for all samples, except for AEP where n= 5 and CtsL where n= 3. Statistical significance was calculated using a two-sided unpaired t-test.
e Quantitative PCR analysis of the mRNA levels for different lysosomal proteases in WT MEFs treated (red squares) or not (blue circles) with 30mg/ml
BSA overnight. Data are the average ± SD of n= 4 biologically independent samples for all samples, except for AEP and CtsD where n= 3. Statistical
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MVO26630 (50 μM) or BSA (30mg/ml) for 16 h. Data are the average ± SD of n= 25 microscopic fields for P-STAT3 and n= 14 for LC3II. Statistical
significance was calculated using a Dunnett’s multiple comparison test. ns= not significant. (Scale bar= 20μm)
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a number of TFEB target genes are involved in autophagy13.
Induction of autophagy alongside increased lysosomal capacity
makes sense under nutrient poor conditions but probably not
under conditions of increased substrate load since this would
likely overload and stress the lysosomal system still further. In
fact, faced with lysosomal overload of undegraded substrates, it
would make sense to temporarily inhibit constitutive autophagy
which is ongoing in most cells49. Consistent with this, there is
extensive evidence that autophagy is indeed inhibited by STAT3,
for example through an inhibitory interaction between protein
kinase R and STAT3 and/or through suppression of beclin
1 synthesis50–52.
The STAT3-driven pathway of increased lysosomal capacity
was observed in different cell types and is likely to be a general
response to lysosomal stress-induced by protease insufficiency/
substrate accumulation. It may however be particularly relevant
in the kidney whose PTC are tasked with reabsorption and
processing of a continual macromolecule load present in the
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glomerular ultrafiltrate. Faced with an increased protein load as
occurs in proteinuria, PTC likely need to increase lysosomal
capacity. Indeed, in focal segmental glomerulosclerosis (FSGS), a
model of glomerular injury, proteinuria led not only to increased
lysosome protein content but also to an apparently adaptive
increase in some lysosomal proteases53. A mechanistic basis for
this was not elucidated but based on our results it seems likely
that proteinuria leads to lysosomal stress, activation of STAT3 in
PTC and that this is the basis of increased biosynthesis of lyso-
somal hydrolases. Activation of STAT3 as a result of lysosomal
stress may explain some of the inflammatory features of protei-
nuric kidney disease. Linked to this, other studies have shown
that protein overloaded proximal tubular cells express several
vasoactive and inflammatory mediators54 and that the Jak/STAT
pathway was activated following protein overload of PTC
in vitro55. With a full complement of lysosomal protease genes
available, resolution of lysosomal overload would be expected to
extinguish the oxidative stress that drives STAT3 activation and
consequently, return hydrolase transcription to normal levels.
However, when a critical gene such as AEP is missing and
accumulation of target substrates continues, STAT3 activation
becomes chronic likely explaining the onset of the severe pro-
liferative kidney disease in AEP-null mice26.
Oxidative stress is a common feature of lysosomal storage
diseases (LSD) but how these diverse genetic deficiencies lead to
oxidative stress is not fully understood43 and this is also the case
in AEP-deficient cells. However, it is known that loss or mutation
of another lysosomal protease, CtsD can lead to congenital neu-
ronal ceroid-lipofuscinosis characterised by accumulation of
lipofuscin laden vacuoles and oxidative damage to brain pericytes
and other cells16. Other studies show that intracranial adminis-
tration of the pan-lysosomal cysteine protease inhibitor, leupeptin
also led to ceroid–lipofuscin accumulation in rat brain56. Lipo-
fuscin is a complex undegraded material, rich in protein, lipid,
carbohydrates and transition metals, that is associated with the
generation of reactive oxygen species57. Thus while the details of
how oxidative stress-induced by protease/substrate imbalance
remain to be clarified, there is clear evidence that lysosomal
proteases are non-redundantly required for normal lysosomal
homoeostasis and that their loss leads to various forms of lyso-
somal stress and downstream pathology.
The lysosome-mediated pathway of cell death has been well
characterised58 but has only recently been shown to be physio-
logically important. Watson and colleagues have provided strik-
ing evidence that post-lactational involution of the mammalian
mammary gland is achieved by lysosome-mediated programmed
cell death (LM-PCD), dependent on STAT3 activation7,8. STAT3
increased expression of CtsB and CtsL and increased uptake of
milk fat globules which, upon hydrolysis, released lysosome-
permeabilising unsaturated fatty acids which were essential for
the induction of LM-PCD. We suggest that the STAT3-driven
pathway of lysosomal hydrolase expression may primarily be one
for lysosomal adaptation to greater substrate load as shown here.
However, as shown by studies in the involuting mammary gland,
when combined with perturbations to the lysosomal membrane it
can also be used to drive LM-PCD.
In summary, our results shed light on how cells can adjust their
lysosomal hydrolytic capacity under conditions of nutritional
sufficiency rather than insufficiency which leads to TFEB acti-
vation. Communication between the lysosomal lumen and the
cytosol appears to depend on lysosomal stress signals rather than
lysosomal amino acid levels. Finally, there is great interest in
manipulation of the lysosomal system, for example through TFEB
activation, to enhance clearance of protein aggregates that can
lead to pathology for example in neurodegenerative disease. Our
results may suggest additional strategies involving the
STAT3 signalling axis and potentially AEP inhibition, which as
shown here can lead to extensive adaptational changes that
overall, boost lysosome performance.
Methods
Antibodies. All antibodies used in this manuscript were used a 1:1000 dilution
when used for immunoblotting and 1:200 when used for immunofluorescence.
Antibodies against P-STAT3 (D3A7), STAT3 (124H6), P-Jak2 (D2E12), Jak2
(3771A), P-4EBP1 (236B4), LC3 (D3U4C) and GAPDH (14C10) were obtained
from Cell Signaling. Antibodies against Laminin (ab11575), CtsD (ab75852), CtsB
(ab92955), Lamp1 (ab24170) and Fibronectin (ab199056) were purchased from
AbCam. Anti-Ki67 (B56) obtained from BD Bioscience, anti-Gns (13044-1-AP)
from ProteinTech, anti-TFEB (A303-673A) from Bethyl, anti-YM1 (60130) from
Stem Cell Technologies, anti-EGFR (sc-03) from SantaCruz, anti-OSMRβ (3458-
100) from R&D System and anti-SOD1 (3458-100) from BioVision.
Mice and cell culture. WT and AEP−/−mice on a C57BL/6 background, generated
as previously reported59, were bred and maintained under pathogen-free conditions
under UK Home Office Project License PPL60/3851 and with project approval from
the University of Dundee Ethical Review Committee. WT and AEP-null primary
murine embryonic fibroblast (MEF) were generated from WT or AEP−/− mice as
previously described60 and expanded using complete Dulbecco’s modified Eagle
medium (DMEM) supplemented with 100 U/ml penicillin, 100 μg/ml streptomycin,
2 mM L-glutamine, 1% pyruvate, 1% non-essential amino acids and 10% FBS. For
protein overload experiments, wildtype MEF were incubated with bovine serum
albumin (30mg/ml) on coverslips for immunofluorescence experiments or in 6 well
plates to measure lysosomal proteolytic activities. HKC-8, a human-derived prox-
imal tubule cell line33, were cultured in 1:1 Dulbecco’s modified Eagle’s—F12
medium supplemented with 100 U/ml penicillin, 100 μg/ml streptomycin, 2 mM L-
glutamine and 5% FBS.
Fig. 7 Reactive oxygen species: At the nexus between lysosomal hydrolytic capacity and STAT3 phosphorylation. a Superoxide dismutase 1 (SOD1) activity
in WT and AEP−/− MEFs. Data are the average ± SD of n= 3 biologically independent samples. Statistical significance was calculated using a two-sided
unpaired t-test. b SOD1 activity in WT MEFs treated for 16 h with increasing concentrations of MVO26630. Data are the average ± SD of n= 3 biologically
independent samples. Statistical significance was calculated using a Dunnett’s multiple comparison test. c MVO26630-induced (6 h, 50 μM) STAT3
activation in the presence of increasing concentrations of alpha Phenyl-N-Tert Butyl Nitrone (PBN). Data are the average ± SD of n= 3 biologically
independent samples. Statistical significance was calculated using a Dunnett’s multiple comparison test. d Cellular distribution of TFEB-GFP (upper panels)
and STAT3-YFP (lower panels) in HKC-8 WT treated or untreated with 0.2 mM H2O2 for 16 h. Quantitative data show the nuclear fluorescence intensity
per cell (n= 79 for TFEB control, n= 99 for TFEB+H2O2, n= 59 for STAT3 control and n= 58 for STAT3+H2O2). Statistical significance was calculated
using a two-sided unpaired t-test. (Scale bar= 20μm). e Levels of CtsD in HKC-8 WT cells treated with 0.2 mM H2O2 for 16 h. Data are the average ± SD
of n= 3 biologically independent samples. Statistical significance was calculated using a two-sided unpaired t-test. f Quantitative PCR analysis of the
mRNA levels encoding several different lysosomal proteases in WT MEFs treated or not with 0.2 mM H2O2 overnight. Data are the average ± SD of n= 4
biologically independent samples for all samples, except for CtsH where n= 3. Statistical significance was calculated using a two-sided unpaired t-test.
g Live cell imaging of lysosomal production of reactive oxygen species using CellROX Orange (CRO) in AEP−/− or WT MEFs treated or not with 50 μM
MVO26630 for 16 h. LysoTracker Green DND26 (LTG) was used as a lysosomal marker. Data represent the mean CRO intensity per lysosome normalised
to lysosomal size in µm2 (n= 1254 lysosomes for WT MEFs sample, n= 1413 lysosomes for WT MEFs+MVO sample and n= 1204 for AEP MEFs). (Scale
bar= 10μm). Statistical significance was calculated using a Dunnett’s multiple comparison test
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Isolation of human primary proximal (PTC) and distal tubular cells (DTC).
Human kidneys cells were isolated from adult kidneys after surgical resection in
accordance with the Research Ethics Committee guidelines and approval granted
by the NRES Committee East Midlands-Derby (REC reference 13/EM/0311) as
previously described61. Informed patient consent was obtained as part of this
approval. Kidney cortex was minced and digested with 1 mg/ml collagenase IV for
60 min at 37 °C and passed through a 40 µm cell strainer. After centrifugation at
300×g, the pellet was resuspended in RPMI and loaded in a two layer Percoll
gradient (50%, 24.6%). Centrifugation at 1000×g for 25 min at 4 °C produced three
separate layers: a top layer containing DTC and a middle layer containing PTC
were retrieved and separately washed twice in RPMI at 300×g. DTC were seeded
and maintained in DMEM/F-12, GlutaMAX™ supplemented with 100 U/ml peni-
cillin, 100 µg/ml streptomycin, 2 mM L-glutamine, 10% FBS and maintained at
37 °C in an atmosphere of 5% CO2. PTC were seeded and maintained in REGM
BulletKit media from Lonza supplemented with 100 U/ml penicillin, 100 µg/ml
streptomycin. Cells were used between passage 2 and 3. Phenotypic PTC and DTC
confirmation was obtained by electron microscopy.
Transmission electron microscopy. The kidney cortex was cut into small (1 mm
thick) pieces, and immediately fixed in Karnovsky’s fixative (2.5% glutaraldehyde,
4% paraformaldehyde in 100 mM cacodylate buffer pH 7.2). After washing twice in
cacodylate buffer and post-fixing in 1% OsO4 in cacodylate buffer for 60 min, the
samples were dehydrated in alcohol, transferred to 100% propylene oxide and
finally incubated overnight on a rotator in 50% propylene oxide: 50% Durcupan
resin (Sigma). After transfer to 100% Durcupan resin and polymerisation at 60 °C
overnight, sections (70–100 nm thick) were cut using an ultramicrotome (Leica
Ultracut UCT) and stained with 3% uranyl acetate followed by Reynolds lead
citrate (1.33 g lead nitrate, 1.76 g sodium citrate, 8 ml 1M NaOH in 50 ml water).
Grids were imaged on a JEOL 1200 TEX TEM and images were collected on Digital
Imaging Plates and scanned on a Ditabis Micron scanner (Pforzheim, Germany).
Enzymatic activity assays. Cell lysates were prepared in 0.2 M Na citrate buffer
pH 4.0 containing 1% Triton X-100. To measure AEP and CtsB/L activities 20 μg of
total protein were incubated in 200 μl assay buffer (0.2 M Na citrate buffer pH 4.0,
1 mM DTT) containing 10 μM AEP substrate [Z-Ala-Ala-Asn-7-amino-4-methyl
coumarin (AMC)] or 10 μM CtsB/L substrate [Z-Phe-Arg-AMC], respectively.
AMC release was quantified at 460 nm in a fluorescence plate reader (Fluorostar
Optima, BMG Labtech), and activities calculated as arbitrary units. CtsD/E activ-
ities were measured under the same conditions but using 50 μg of cell lysate, 10 μM
CtsD/E substrate [MCA-Gly-Lys-Pro-Ile-Leu-Phe-Arg-Leu-Lys(Dnp)-D-Arg-
NH2] and MCA release measured at 390 nm. Activities were calculated as arbitrary
units.
Superoxide dismutase [Cu-Zn] (SOD1) activity was determined using 20 μg of
total cell lysate (TBS plus 1% Triton X-100) from WT or AEP−/− MEF treated or
untreated with different inhibitors using the Superoxide Dismutase Assay Kit
following the manufacturer’s instructions (ScienCell Research Laboratories).
Immunofluorescence microscopy. Kidneys were removed immediately from
culled WT and AEP−/− mice and fixed in 10% buffered formalin and embedded in
paraffin blocks. Sections (5 μm thick) were cut, deparaffinised using Histo-Clear
and subjected to antigen retrieval using pressure cooking in Na citrate buffer, pH
6.0. Sections were permeabilized with 1× TBS supplemented with 0.025 % Triton x-
100 and blocked with 10% FBS and 1% BSA in TBS prior to overnight staining at 4
°C with the following primary antibodies prepared in TBS, 1% BSA: rabbit anti-P-
STAT3, mouse anti-Ki67, rabbit anti-laminin, rabbit anti-CtsD, rabbit anti-Gns,
rabbit-anti-TFEB, rabbit anti-P-4EBP1 (dilution 1:200). After washing in TBS
0.025% Triton X-100 twice, the slides were incubated for 1 h with the appropriate
Alexa-488- or Alexa 594-conjugated secondary antibody (Invitrogen, dilution
1:500) in TBS with 1% BSA. The slides were finally washed three times in TBS and
mounted under coverslips using Vectashield mounting medium containing DAPI
(Vector Laboratories) and viewed using an LSM 700 confocal microscope (Carl
Zeiss).
WT and AEP−/− MEF (5 × 104 cells/coverslip) were fixed with 4%
paraformaldehyde in PBS at room temperature for 20 min or with 100% methanol
at −20 °C for 10 min. The cells were washed three times with PBS, permeabilized
with 0.2% Triton X-100 in PBS for 20 min at room temperature, washed 3× with
PBS and then incubated for 20 min at room temperature in blocking buffer (1%
BSA in TBS). The cells were stained using a 1:200 dilution of primary antibody in
blocking buffer for 45 min at room temperature (rabbit anti-TFEB, rabbit anti-LC3
or rabbit anti-P-STAT3), washed three times with PBS and stained with a 1:500
dilution of the Alexa-488-conjugated secondary antibody (Invitrogen) for another
45 min at room temperature. Coverslips were washed three times with PBS 1× and
mounted using Vectashield mounting medium containing DAPI (Vector
Laboratories) and viewed using an LSM 700 confocal microscope (Carl Zeiss).
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Fig. 8 Activation of STAT3 in AEP−/− kidney and enhanced hydrolase expression in STAT3c kidneys. a STAT3 and P-STAT3 levels in WT and AEP−/−
kidneys. b P-STAT3 detected by IF in WT and AEP−/− kidney sections. Right panel shows quantitation of the number of P-STAT3 positive nuclei per area
(n= 35 microscopic fields). (Scale bar= 100μm). Statistical significance was calculated using a two-sided unpaired t-test. c Ki67 and laminin detected by
IF in WT and AEP−/− kidney sections. (Scale bar= 20μm). d Similar proteins accumulate in STAT3c and AEP−/− kidney. e Levels of P-STAT3 and CtsD in
proximal (PTC) and distal (DTC) tubular cells treated or not with 50 μM MVO26630 overnight. Data are the average ± SD of n= 5 biologically
independent samples for PTCs and n= 3 for DTCs. Statistical significance was calculated using a two-sided unpaired t-test
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-018-07741-6
12 NATURE COMMUNICATIONS |          (2018) 9:5343 | https://doi.org/10.1038/s41467-018-07741-6 | www.nature.com/naturecommunications
STAT3-YFP and TFEB-GFP cellular distribution in HKC-8 cells. The TFEB-GFP
construct was purchased from Acris Antibodies. STAT3-YFP was cloned into
pcDNA5. HKC-8 cells (5 × 104 cells/coverslip) were transfected with STAT3-YFP
or TFEB-GFP using polyethylenimine (PEI)62 and 24 h later cells were treated as
indicated in the figure legends. After fixation with 4% paraformaldehyde in PBS at
room temperature for 20 min the coverslips were washed three times with PBS 1×
and mounted using Vectashield mounting medium containing DAPI (Vector
Laboratories) and viewed using an LSM 700 confocal microscope (Carl Zeiss).
TFEB knockout generation in HKC-8 cells. Two different TFEB knockouts were
generated by targeting TFEB exon 1 or exon 2. The sense guides (exon 1:
GCATGCAGCTCATGCGGGAGC; exon 2: GTGCCCCAGCAGCATCCCCAG)
were cloned into the pBABED puro U6 and the antisense guides were cloned into
the Cas9 D10A vector pX355 (exon 1: GCAGCCCGATGCGTGACGCCA; exon 2:
GGCTTCGGGGAACCTTGGGC).
HKC-8 cells (106 cells/10 cm dish) were transfected with the sense and antisense
guide plasmids targeting exon 1 or exon 2 of the TFEB gene using PEI. Twenty-
four hours later the media was replaced with media supplemented with 2 μg/ml
puromycin. After 48 h of puromycin selection transfected cells were expanded and
individual clones were isolated and tested for TFEB expression by western blotting.
Jak2 knockdown in HKC-8 cells. A set of four Jak2-siRNAs were purchased from
Dharmacon and tested individually to determine levels of knockdown achieved.
The siRNAs providing the highest level of Jak2 knockdown (siRNA #6:
GAAUUGUAACUGUCCAUAA and siRNA #7: GAAUUUAUGCGAAU-
GAUUG) were subsequently used in all the experiments.
HKC-8 cells (104 cells per well) in a 96 well plate were transfected with Jak2-
siRNAs or non-targeting siRNA (UGGUUUACAUGUCGACUAA) (Dharmacon)
using DharmaFect 1 transfection reagent (Dharmacon) following the
manufacturer’s instructions. Forty-eight hours later cells were treated as indicated
and samples prepared for SDS-PAGE analysis.
STAT3 knockdown and rescue in HKC-8 cells. A set of four STAT3-siRNAs
were purchased from Dharmacon and tested individually to determine levels of
knockdown achieved. The siRNAs providing the highest level of STAT3
knockdown (siRNA #8: CAACAUGUCAUUUGCUGAA and siRNA #10: CAA-
CAGAUUGCCUGCAUUG) were subsequently used in all the experiments. HKC-
8 cells (104 cells per well) in a 96 well plate were transfected with STAT3-siRNAs or
non-targeting siRNA (UGGUUUACAUGUCGACUAA) (Dharmacon) using
DharmaFect 1 transfection reagent (Dharmacon) following the manufacturer’s
instructions. Forty-eight hours later cells were treated as indicated and samples
prepared for SDS-PAGE analysis
To generate a form of STAT3 refractory to siRNA knockdown, we fused it to
GFP to distinguish it from endogenous STAT3 (mSTAT3-GFP) and introduced
mutations into the target sequence for siRNA #8 (see above) using the following
primers 5′-GCAGCTGAACAACATGTCATTTGCTGAAATCATCATG-3′ and
5′-CATGATGATTTCAGCAAATGACATGTTGTTCAGCTGC-3′. HKC-8 cells
were transiently transfected using PEI and GFP-positive cells were enriched by
FACS using an Influx cell sorter (Becton Dickinson). Cells were distinguished from
debris based on FSC-H vs SSD-H and single cells on the basis of FSC-A vs FSC-W
measurements. GFP-positive cells were identified based on background
fluorescence levels in the parental cell line negative control. Then, sorted cells were
expanded for 48 h in the presence of G418 to maintain plasmid expression prior to
siRNA (#8 or non-targeting) transfection. Knockdown of endogenous STAT3
versus mSTAT3-GFP was assessed by western blotting and STAT3 activation by
MVO-treatment was performed and analysed as previously described
STAT3 ChIP-PCR. Anti-STAT3 ChIP was carried out as previously reported63.
Briefly, WT and AEP−/− MEFs were grown to 70% confluency, crosslinked with
1% formaldehyde for 10 min at RT. Excess formaldehyde was blocked with 0.125M
glycine and the cells washed with ice-cold PBS several times after which the cells
were scraped off in 2 ml of PBS containing protease inhibitors and collected by
centrifugation at 500×g for 10 min at 4 °C. Pellets were resuspended in lysis buffer
(1% SDS, 10 mM EDTA, 50 mM Tris–HCl (pH 8.1) and protease inhibitors) and
sonicated three times for 5 min in a BioRuptor RTH (30 s on/30 s off). Samples
were then diluted 1:10 in ChIP dilution buffer (1% Triton X-100, 2 mM EDTA,
150 mM NaCl, 20 mM Tris–HCl (pH 8.1)) and anti-STAT3 antibody was added to
the samples (Cell Signaling, 124H6) and incubated overnight at 4 °C. Finally
immunoprecipitated chromatin was purified using the iPure Kit (Diagenode) fol-
lowing the manufacturer’s instructions.
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The samples were then tested for the presence of the promoter regions of genes
of interest by PCR using the following primers:
STAT3 (forward: GGTGACACCTGGGGACCGCCTAAG; reverse:
AAAAACGCCTCTAGGAGAGAAGGCG),
AEP (forward: ATGAGTTGGCCCTGTTTTGGGTCC; reverse:
TCTGCCTTGGCCTATGATCACAAC),
CtsL (forward: AAAACAGTCTCCATCGTTCTCAAC; reverse:
GGCCTGCTGTGGAATTTCCACCTC),
CtsD (forward: AGAGTGAAGTAGTTAAGACCCAAG; reverse:
TACCAGGATGTGGTCTTTGTCTGA),
Gns (forward: GGAAGGTGCGTGAGCACGCAAAAC; reverse:
GGACAGAGCACCGGAGATGAAGAC),
Man2b2 (forward: GATAGAGAGGGATCTGAGCTTGCT; reverse:
CAGAATCAAATCTGGGGTCTTGGA),
Naga (forward: GTTAAGAGCAAGGTTTCAGGTGGA; reverse:
GTTCTGCGCGTTCCCGAGGCGCGC),
Plbd2 (forward: TGCAGAGGACTTGAGTTCGAATTC; reverse:
CTCAGCATCCTTCCCTCCCAAGGA).
The sequence of the primers used as negative controls was: (forward:
ATGGTTGCCACTGGGGATCT; reverse: TGCCAAAGCCTAGGGGAAGA)
Electrophoretically separated PCR products were quantified with ImageJ and
normalised to input samples.
Generation of 13C6-Lysine SILAM mouse colony. An in-house breeding colony
of C57BL/6 13C6-Lysine ‘SILAM’ labelled mice was generated using specialised
13C6-Lysine mouse diet (Silantes, Martinsried, Germany) following the breeding
programme previously described by Krüger et al.29 Labelling efficiency was mon-
itored for brain, liver and skin tissues from 19 weeks old F0 (fed 13C6-Lysine mouse
diet for 16 weeks), 8-week-old F1 and 8-week-old F2 animals. Labelling efficiencies
for all confidently (1% false discovery rate) assigned peptides were calculated as:
heavy_peptide_area /(heavy_peptide_area+ light_peptide_area). For all tested
samples, ~90% of the peptides were > 90% 13C6-Lysine-labelled at the F2 genera-
tion. Tissues used for this study were acquired from F4 C57BL/6 13C6-Lysine
SILAM females.
Kidney lysosome SILAC-based mass spectrometry. Kidney lysosomes from L-
lysine-13C6 labelled WT mice and unlabelled WT or AEP−/− mice were prepared
as previously described26. 60 μg of unlabelled WT or AEP−/− kidney lysosomal
proteins were combined in a 1:1 ratio with 60 μg of L-lysine-13C6 labelled WT
kidney lysosomal proteins. Protein samples were prepared for LC-MS/MS using the
FASP protocol as previously described64. Briefly, the protein mixture was dena-
tured at 95 °C for 5 min in SDS-lysis buffer (4% (w/v) SDS, 100 mM Tris–HCl pH
7.6, 0.1 mM DTT) and the samples were mixed with 200 μl of 8 M urea in 0.1
Tris–HCl pH 8.5 (UA buffer) in a Microcon YM-10 filter unit and centrifuged at
17,000×g for 40 min. Samples were washed again with another 200 μl of UA buffer
and then treated with 100 μl of 0.05 M iodoacetamide in UA buffer for 20 min at
room temperature. After three further washes with 100 μl UA buffer and three
times with 0.05M NH4CO3 (ABC buffer) centrifuging each time at 14,000×g for 15
min and discarding the flow through, the protein mixture was digested overnight at
37 °C in the YM-10 filter unit using 40 μl of 0.4 μg/μl trypsin in ABC buffer. The
samples containing the tryptic peptides were collected by centrifugation at
14,000×g for 40 min and 50 μl of 0.5 M NaCl was added to the YM-10 filters
followed by centrifugation for another 20 min at 14,000×g. Tryptic peptides were
finally desalted using a C18-SD cartridge, treated with 0.1% trifluoroacetic acid and
eluted in 70% acetonitrile.
MEF SILAC-based mass spectrometry. MEF were cultured for at least 10 days in
RPMI without arginine and lysine (Biosera) containing 10% dialysed FCS
(Hyclone), 100 U/ml penicillin, 100 μg/ml streptomycin, 2 mM L-glutamine, 1%
pyruvate, 1% non-essential amino acids and supplemented with 84 mg/l of L-
arginine (Sigma) and 40 mg/l of L-lysine (Sigma) for the ‘light’ medium or 106 mg/
ml of L-arginine-13C6-15N4 and 50 mg/ml of L-lysine-13C6 for the ‘heavy’ medium.
Equal numbers of cells were mixed and cytoplasmic, membrane and nuclear
fractions were obtained using a subcellular protein fractionation kit for cultured
cells (Thermo) according to the manufacturer’s instructions. 100 μg of protein was
size-fractionated by SDS-PAGE using 4–12% NuPAGE gels (Invitrogen) in MES
running buffer, stained using SimplyBlue Safe Stain (Invitrogen) and destained
using miliQ water. The gels were cut into 15 × 0.5 cm slices using a clean scalpel
and cut into 1 mm cubes. After washing with 50% acetonitrile/water, 0.1 M
NH4CO3 and 50% acetonitrile in 50 mM NH4CO3 (0.5 ml) the samples were
treated with 75 μl of 10 mM DTT in 0.1 M NH4CO3 and incubated for 20 min at
37 °C. The liquid was removed and proteins in the gel pieces were carbox-
ymethylated with 50 mM iodoacetamide in 0.1 M NH4CO3 for 20 min at room
temperature in the dark. The gel pieces were washed with 50% acetonitrile in
50 mM NH4CO3, shrunk using 0.3 ml acetonitrile per piece for 15 min and after
removal of the supernatant, dried using a Speed-Vac lyophiliser. The protein
content of each piece was digested with 30 μl 5 μg/ml of trypsin in 25 mM trie-
thylammonium bicarbonate at 30 °C overnight. An equal volume of acetonitrile
was added and the mixture was shaken at 30 °C for 15 min. The supernatants,
containing the tryptic peptide mixture from each sample, were frozen in liquid
nitrogen and dried using a Speed-Vac. Meanwhile, the gel pieces were treated with
100 μl of 50% acetonitrile, 2.5% formic acid in water and shaken for 10 min at
30 °C. This second supernatant was combined with the first, frozen down in liquid
nitrogen and then dried in a Speed-Vac.
Mass spectrometry. A nanoflow liquid chromatograph (Ultimate 3000 RSLCnano
system, Thermo) coupled to a LTQ Orbitrap Velos Pro mass spectrometer
(Thermo) was used to analyse the protein digests. Samples, usually 10 μl, were
loaded onto a C18 trap column and washed with 0.1% formic acid. The peptides
were resolved using a gradient (130 min, 0.3 μl/min) of buffer A (0.1% formic acid)
and buffer B (80% acetonitrile in 0.08% formic acid): 2% buffer B for 4 min
followed by 2–40% buffer B for 64 min, 40–98% buffer B for 2 min, 98% buffer B
for 15 min, 98–2% buffer B for 1 min and 2% buffer B for 44 min. Peptides, initially
trapped on an Acclaim PepMap 100 C18 column (100 μm× 2 cm, Thermo) were
then separated on an Easy-Spray PepMap RSLC C18 column (75 μm× 50 cm,
Thermo), and finally transferred to the LTQ Orbitrap Velos Pro via an Easy-Spray
source set at 50 °C and a source voltage of 1.9 kV. For the identification of peptides,
a top 15 method (FT-MS plus 15 IT-MS/MS, 100 min acquisition) consisting of full
scans and mass range (m/z) between 335 and 1800 was used. The Orbitrap was
operated in a profile mode, resolution of 60,000 with a lock mass set at 445.120024
and a max fill time of 500 ms. LTQ was operated in a centroid mode with isolation
width= 2.00 (m/z), normalised collision energy= 35.0, activation time= 10.0 ms
and max fill time of 100 ms.
Mass spectrometry data analysis. LTQ Orbitrap Velos Pro.RAW files were
analysed, and peptides and proteins quantified using MaxQuant65, using the built-
in search engine Andromeda66. All settings were set as default, except for the
minimal peptide length of 5, and Andromeda search engine was configured for the
UniProt Mus musculus protein database (release date: 2013_10). Peptide and
protein ratios only quantified in at least two out of the three replicates were
considered, and the p-values were determined by Student´s t test and corrected for
multiple testing using the Benjamini–Hochberg procedure65.
Sample preparation and immunoblotting. Tissue samples were prepared using a
7-ml dounce tissue grinder (Wheaton, USA) in complete RIPA buffer (RIPA buffer
(Thermo) supplemented with 1 mM sodium orthovanadate, 10 mM sodium
fluoride and 1 protease inhibitor tablet (Roche)). WT and AEP−/− MEFs (2 × 105
cells) treated or untreated with the different inhibitors were washed once with ice-
cold PBS and lysed using complete RIPA buffer. Tissue and cell lysates were
centrifuged at 20,000×g for 10 min and equal amounts of protein loaded on 4–12%
NuPAGE gels (Invitrogen) and then transferred onto nitrocellulose membranes
(Amersham). Membranes were probed with the following antibodies: rabbit anti-P-
STAT3, mouse anti-STAT3, rabbit anti-GAPDH and rabbit anti-LC3 (Cell Sig-
naling), rabbit anti-Ym1 (StemCell Technologies), rabbit anti-EGFR (SantaCruz),
rabbit anti-Lamp1, rabbit anti-CtsD, rabbit anti-Fn1 and anti-CtsB (abCam), rabbit
anti-TFEB (Bethyl) and rabbit anti-Gns (ProteinTech) and goat anti-OSMRβ
(R&D Systems). Sheep anti-AEP was obtained as described previously32 and sheep
anti-CtsL and CtsH were generous gifts from Drs Tina Zavašnik-Bergant and Janko
Kos (Jožef Stefan Institute, Ljubljana, Slovenia)
In vivo cathepsin L activity assay. WT and AEP−/− MEF (5 × 104 cells) were
grown on coverslips and incubated with Magic Red cathepsin L (Immunochemistry
Technologies) for 60 min at 37 °C following the manufacturer’s instructions. The
cells were then fixed with 4% paraformaldehyde in PBS, mounted using Vectashield
mounting medium containing DAPI (Vector Laboratories) and images were
obtained using a LSM 700 confocal microscope (Carl Zeiss).
Lysosomal degradation of DQ-BSA. WT 3T3 cells (5 × 104 cells) were grown on
coverslips and treated with MVO 50 μM for 16 h. Then, cells were incubated with
10 μg/ml of DQ-BSA (Invitrogen) or 50 μg/ml of FiTC-BSA for 2 h at 37 °C,
washed twice with PBS, then fixed with 4% paraformaldehyde in PBS for 20 min at
room temperature, mounted using Vectashield mounting medium with DAPI
(Vector Laboratories) and images were obtained using an LSM 700 confocal
microscope (Carl Zeiss).
Onconstatin M receptor β (OSMRβ) and epithelial growth factor receptor
(EGFR) degradation assay. Total cell extracts from WT cells treated or not with
50 μM MVO26630 and AEP−/− MEF (2 × 105 cells), incubated as indicated with
oncostatin M 25 ng/ml (R&D Systems) or epithelial growth factor 100 ng/ml and
cycloheximide (10 μg/ml), were prepared in complete RIPA buffer and equal
amounts of protein were separated by SDS-PAGE and subjected to direct Western
blotting using anti-OSMRβ or anti-EGFR as described above.
In-cell reactive oxygen species determination. WT and AEP−/−MEF grown on
FluoroDish dishes (World Precision Instruments Inc.) treated as indicated with the
different inhibitors were incubated with 100 nM LysoTracker Green DND26
(Invitrogen) for 2 h at 37 °C and then with 2.5 μM CellROX Orange (Invitrogen)
for 30 min at 37 °C. The cells were washed twice with PBS, fresh complete DMEM
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was added to the dishes and live cell imaging carried out at 37 °C and 5% CO2
using a LSM 700 confocal microscope (Carl Zeiss). CellROX Orange intensity
overlapping with LysoTracker Green DND26 positive structures was quantified
using the Volocity 3D Image Analysis Software (PerkinElmer). The mean intensity
of CellROX Orange per LysoTracker Green DND26 positive structure, normalised
for lysosomal size (µm2) and per cell was calculated and the standard error cal-
culated using 15 cells per experimental condition.
Semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR).
Total RNA from WT MEF, treated or untreated with 50 μM MVO26630 overnight,
and AEP−/− MEFs, WT and STAT3c 3T3s was purified using RNeasy mini kit
(Qiagen) following the manufacturer’s instructions. Total RNA concentration was
determined using a NanoDrop 1000 spectrophotometer (Thermo) and 1 μg of total
RNA per sample was used to synthesise cDNA using the qScript Flex cDNA kit
(Quanta Biosciences) according to the manufacturer’s conditions. Finally, the
mRNA expression levels of different lysosomal proteases were determined by PCR,
quantified using ImageJ (imagej. nih.gov) and normalised using β-actin or Tubulin
5 as loading control. The following primers were used: β-actin: forward
(ATCATGTTTGAGACCTTCAACA), reverse (CATCTCCTGCTCGAAGTCTA);
Tubb5: forward (TGTACTATAATGAAGCCACAGGTGG), reverse (CAGTAG
GTCTCATCCGTGTTCTCAA); AEP: forward (ATGACCTGGAGAGTGGCTG),
reverse (CGTTGATGTCGTCGGGCA); CtsB: forward (GGGTACTTAGGAG
TGCACGG), reverse (CCAAATGCCCAACAAGAGCC); CtsD: forward (TCAGG
AAGCCTCTCTGGGTA), reverse (CTGCAGCTCCTTCACCTCTT); CtsH: for-
ward (ATGACGAGGCTGCAATGGTT), reverse (TCCCTTGGTCTGCCAATC
AG); CtsL: forward (ATGGCACGAATGAGGAAGAG), reverse
(GAAAAAGCCTCCCCTTCTTG) and CtsZ: forward (CAGCGGATCTCCCCAA
GAAT), reverse (GTCCTTGGCCTGGTAGTTGT).
Total RNA from HKC-8 WT or TFEB KOs was purified using RNeasy mini kit
(Qiagen) following the manufacturer’s instructions. Total RNA concentration was
determined using a NanoDrop 1000 spectrophotometer (Thermo) and 1 μg of total
RNA per sample was used to synthesise cDNA using the qScript Flex cDNA kit
(Quanta Biosciences) according to the manufacturer’s conditions. Finally, the
mRNA expression levels of different lysosomal proteases were determined by PCR,
quantified using ImageJ (imagej. nih.gov) and normalised using β-actin as loading
control. The following primers were used: β-actin: forward
(GGGGTGTTGAAGGTCTCAAA), reverse (GGCATCCTCACCCTGAAGTA);
CtsB: forward (CGCTTTCCATTCCTGGGTCTCTG), reverse
(ACAGGCCATGTGAGCCACCG); CtsD: forward
(CCCACACACACCCACACACTCG), reverse
(CCAGGGAGGGGAAAACCACAGA).
HKC-8 WT AND TFEB KOs Starvation. Total cell extracts from HKC-8 WT and
TFEB KO cells starved or not for 4 h in HBSS at 37 °C and 10% CO2 were prepared
in complete RIPA buffer and equal amounts of protein were separated by SDS-
PAGE and subjected to direct Western blotting using anti-LC3 or anti-CtsB as
described above.
GO analysis. ClueGo66 within the Cytoscape software67 was used to find statis-
tically over-represented gene ontology (GO) categories. The identified proteins
from the kidney lysosomal SILAC-based mass spectrometry analysis were used as a
test dataset and a reference set of GO annotations for the mouse proteome was
used in order to carry out the GO enrichment analysis. Analyses were done using a
right-sided hypergeometric test and all GO terms corresponding to cellular location
or molecular function with p < 0.005 were selected.
Data availability
The authors declare that all primary data are available in main or Supplementary
figures. The mass spectrometry proteomics data have been deposited to the Pro-
teomeXchange Consortium via the PRIDE partner repository with the dataset
identifier PXD011473. All other data that support the findings of this study are
available from the corresponding authors upon reasonable request
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